首页> 外文期刊>Urologic oncology >MiR-154 inhibits prostate cancer cell proliferation by targeting CCND2
【24h】

MiR-154 inhibits prostate cancer cell proliferation by targeting CCND2

机译:MiR-154通过靶向CCND2抑制前列腺癌细胞的增殖

获取原文
获取原文并翻译 | 示例
       

摘要

Background: Research has shown reduced expression levels of miR-154 in prostate cancer (CaP). However, the function and molecular mechanisms of miR-154 in this cancer type remains unknown. Objective: The aims of this study were to examine the functional significance of miR-154 in CaP cells and to identify the novel molecular targets regulated by miR-154. Materials and methods: miR-154 expression significantly decreased in primary CaP samples compared with nonmalignant samples measured by quantitative reverse transcription polymerase chain reaction. Restoration of miR-154 lowered the potential of CaP cell lines to grow and proliferate in vitro evaluated by CCK-8 assay, colony formation assay, and flow cytometry. miR-154 down-regulated the expression of CCND2 by binding to its 3'-untranslated region by luciferase reporter assay. Conclusions: miR-154 plays a prominent role in CaP proliferation by suppressing CCND2, and it may provide a new approach to the treatment of CaP.
机译:背景:研究表明,前列腺癌(CaP)中miR-154的表达水平降低。但是,miR-154在这种癌症类型中的功能和分子机制仍然未知。目的:本研究的目的是检查miR-154在CaP细胞中的功能意义,并确定miR-154调控的新型分子靶标。材料和方法:与定量测定的逆转录聚合酶链反应的非恶性样品相比,初级CaP样品中的miR-154表达显着降低。通过CCK-8分析,集落形成分析和流式细胞仪评估,miR-154的还原降低了CaP细胞系在体外生长和增殖的潜力。 miR-154通过萤光素酶报告基因检测方法结合CCND2的3'-非翻译区,从而下调CCND2的表达。结论:miR-154通过抑制CCND2在CaP增殖中起重要作用,可能为CaP的治疗提供新的方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号